1
|
Klosen P. Thirty-seven years of MT1 and MT2 melatonin receptor localization in the brain: Past and future challenges. J Pineal Res 2024; 76:e12955. [PMID: 38606787 DOI: 10.1111/jpi.12955] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/26/2023] [Revised: 02/21/2024] [Accepted: 03/31/2024] [Indexed: 04/13/2024]
Abstract
Identifying the target cells of a hormone is a key step in understanding its function. Once the molecular nature of the receptors for a hormone has been established, researchers can use several techniques to detect these receptors. Here I will review the different tools used over the years to localize melatonin receptors and the problems associated with each of these techniques. The radioligand 2-[125I] iodomelatonin was the first tool to allow localization of melatonin receptors on tissue sections. Once the MT1 and MT2 receptors were cloned, in situ hybridization could be used to detect the messenger RNA for these receptors. The deduced amino acid sequences for MT1 and MT2 receptors allowed the production of peptide immunogens to generate antibodies against the MT1 and MT2 receptors. Finally, transgenic reporters driven by the promoter elements of the MT1 and MT2 genes have been used to map the expression of MT1 and MT2 in the brain and the retina. Several issues have complicated the localization of melatonin receptors and the characterization of melatonin target cells over the last three decades. Melatonin receptors are expressed at low levels, leading to sensitivity issues for their detection. The second problem are specificity issues with antibodies directed against the MT1 and MT2 melatonin receptors. These receptors are G protein-coupled receptors and many antibodies directed against such receptors have been shown to present similar problems concerning their specificity. Despite these specificity problems which start to be seriously addressed by recent studies, antibodies will be important tools in the future to identify and phenotype melatonin target cells. However, we will have to be more stringent than previously when establishing their specificity. The results obtained by these antibodies will have to be confronted and be coherent with results obtained by other techniques.
Collapse
Affiliation(s)
- Paul Klosen
- Regulation and Disruption of Neuroendocrine Rhythms, Institute of Cellular and Integrative Neurosciences, INCI CNRS UPR-3212, University of Strasbourg, Strasbourg, France
| |
Collapse
|
2
|
Bartolucci S, Retini M, Fanini F, Paderni D, Piersanti G. Synthesis and Fluorescence Properties of 4-Cyano and 4-Formyl Melatonin as Putative Melatoninergic Ligands. ACS OMEGA 2023; 8:22190-22194. [PMID: 37360469 PMCID: PMC10286092 DOI: 10.1021/acsomega.3c02518] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 04/13/2023] [Accepted: 05/25/2023] [Indexed: 06/28/2023]
Abstract
Fluorescent ligands are imperative to many facets of chemical biology and medicinal chemistry. Herein, we report the syntheses of two fluorescent melatonin-based derivatives as potential ligands of melatonin receptors. The two compounds, namely, 4-cyano and 4-formyl melatonin (4CN-MLT and 4CHO-MLT, respectively), which differ from melatonin by only two/three atoms that are very compact in size, were prepared using the selective C3-alkylation of indoles with N-acetyl ethanolamines involving the "borrowing hydrogen" strategy. These compounds exhibit absorption/emission spectra that are red-shifted from those of melatonin. Binding studies on two melatonin receptor subtypes showed that these derivatives have a modest affinity and selectivity ratio.
Collapse
Affiliation(s)
- Silvia Bartolucci
- Department
of Biomolecular Sciences, University of
Urbino Carlo Bo, Piazza del Rinascimento 6, 61029 Urbino, Pesaro and Urbino, Italy
| | - Michele Retini
- Department
of Biomolecular Sciences, University of
Urbino Carlo Bo, Piazza del Rinascimento 6, 61029 Urbino, Pesaro and Urbino, Italy
| | - Fabiola Fanini
- Department
of Biomolecular Sciences, University of
Urbino Carlo Bo, Piazza del Rinascimento 6, 61029 Urbino, Pesaro and Urbino, Italy
| | - Daniele Paderni
- Department
of Pure and Applied Sciences, University
of Urbino Carlo Bo, Via della Stazione 4, 61029 Urbino, Pesaro and Urbino, Italy
| | - Giovanni Piersanti
- Department
of Biomolecular Sciences, University of
Urbino Carlo Bo, Piazza del Rinascimento 6, 61029 Urbino, Pesaro and Urbino, Italy
| |
Collapse
|
3
|
Boron-containing compounds on neurons: Actions and potential applications for treating neurodegenerative diseases. J Inorg Biochem 2023; 238:112027. [PMID: 36345068 DOI: 10.1016/j.jinorgbio.2022.112027] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2022] [Revised: 09/27/2022] [Accepted: 10/10/2022] [Indexed: 11/06/2022]
Abstract
Boron-containing compounds (BCC) exert effects on neurons. After the expanding of both the identification and synthesis of new BCC, novel effects in living systems have been reported, many of these involving neuronal action. In this review, the actions of BCC on neurons are described; the effects have been inferred by boron deprivation or addition. Also, the effects can be related to those mediated by interaction on ionic channels, G-protein coupled receptors, or other receptors exerting modification on neuronal behavior. Additionally, BCC have exhibited effects by the modulation of inflammation or oxidative processes. BCC are expanding as drugs. Deprivation of boron sources from the diet shows the role of some natural BCC. However, the observations of several new synthesized compounds suggest their ability to act with attractive potency, efficacy, and long-term action on neuronal receptors or processes related with the origin and evolution of neurodegenerative processes. The details of BCC-target interactions are currently being elucidated in progress, as those observed from BCC-protein crystal complexes. Taking all of the above into account, the expansion is presumably near to having studies on the application of BCC as drugs on specific targets for treating neurodegenerative diseases.
Collapse
|
4
|
Ding Y, Shen L, Liang K, Xia C. Synthesis of C2-Carbonyl Indoles via Visible Light-Induced Oxidative Cleavage of an Aminomethylene Group. J Org Chem 2022; 87:16644-16654. [PMID: 36445203 DOI: 10.1021/acs.joc.2c02292] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022]
Abstract
A strategy for photochemical oxidative cleavage of the aminomethylene group at the C2 position of indole was developed to synthesize C2-carbonyl indoles. The reaction was initiated by the photochemical oxidation of N1, followed by a water-assisted concerted H-shift by abstracting hydrogen from aminomethylene. Bromopyridine was discovered to play dual roles as an oxidant for the regeneration of photocatalysts and as an accelerant for the single-electron transfer process.
Collapse
Affiliation(s)
- Yuzhen Ding
- Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan Provincial Center for Research & Development of Natural Products, School of Pharmacy, Yunnan University, Kunming 650091, China
| | - Lei Shen
- Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan Provincial Center for Research & Development of Natural Products, School of Pharmacy, Yunnan University, Kunming 650091, China
| | - Kangjiang Liang
- Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan Provincial Center for Research & Development of Natural Products, School of Pharmacy, Yunnan University, Kunming 650091, China
| | - Chengfeng Xia
- Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan Provincial Center for Research & Development of Natural Products, School of Pharmacy, Yunnan University, Kunming 650091, China
| |
Collapse
|
5
|
Gbahou F, Levin S, Tikhonova IG, Somalo Barranco G, Izabelle C, Ohana RF, Jockers R. Luminogenic HiBiT Peptide-Based NanoBRET Ligand Binding Assays for Melatonin Receptors. ACS Pharmacol Transl Sci 2022; 5:668-678. [DOI: 10.1021/acsptsci.2c00096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2022] [Indexed: 11/28/2022]
Affiliation(s)
- Florence Gbahou
- Université Paris Cité, Institut Cochin, INSERM, CNRS, 75014 Paris, France
| | - Sergiy Levin
- Promega Corporation, Fitchburg, Wisconsin 53711, United States
| | - Irina G. Tikhonova
- School of Pharmacy, Medical Biology Centre, Queen’s University Belfast, Belfast BT9 7BL, United Kingdom
| | | | - Charlotte Izabelle
- Université Paris Cité, Institut Cochin, INSERM, CNRS, 75014 Paris, France
| | | | - Ralf Jockers
- Université Paris Cité, Institut Cochin, INSERM, CNRS, 75014 Paris, France
| |
Collapse
|
6
|
Melatonin Receptors: A Key Mediator in Animal Reproduction. Vet Sci 2022; 9:vetsci9070309. [PMID: 35878326 PMCID: PMC9320721 DOI: 10.3390/vetsci9070309] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2022] [Revised: 06/16/2022] [Accepted: 06/20/2022] [Indexed: 01/26/2023] Open
Abstract
Melatonin, a hormone produced by the mammalian pineal gland, influences various physiological activities, many of which are related to animal reproduction, including neuroendocrine function, rhythm regulation, seasonal behavior, gonadogenesis, gamete development and maturation, sexual maturation, and thermoregulation. Melatonin exerts beneficial actions mainly via binding with G-protein-coupled receptors (GPCR), termed MT1 and MT2. Melatonin receptors are crucial for mediating animal reproduction. This paper reviews the characteristics of melatonin receptors including MT1 and MT2, as well as their roles in mediating signal transduction and biological effects, with a focus on their function in animal reproduction. In addition, we briefly summarize the developments in pharmacological research regarding melatonin receptors as drug targets. It is expected that this review will provide a reference for further exploration and unveiling of melatonin receptor function in reproductive regulation.
Collapse
|
7
|
Wang J, Boens N, Jiao L, Hao E. Aromatic [b]-fused BODIPY dyes as promising near-infrared dyes. Org Biomol Chem 2021; 18:4135-4156. [PMID: 32441725 DOI: 10.1039/d0ob00790k] [Citation(s) in RCA: 63] [Impact Index Per Article: 21.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Far-red and near-infrared (NIR) absorbing/emitting dyes have found diverse applications in biomedicine and material science. However, the absorption and emission of classical BODIPY chromophores at short wavelength hamper their applications. Several strategies have been adopted to modify the structure of the BODIPY core to design NIR dyes. Among these, the most efficient approach to expand the π-conjugation of the BODIPY core is via fusion of aromatic rings. So far, many novel BODIPY skeletons fused to aromatic hydrocarbons and heterocycles at the b bond have been reported. This review comprehensively describes the recent advances regarding the development of aromatic [b]-fused BODIPY dyes with the focus on the design and synthesis, the relationships between their photophysical/spectroscopic properties and molecular structures, and the potential applications in bioassays and optoelectronic devices.
Collapse
Affiliation(s)
- Jun Wang
- Laboratory of Functional Molecular Solids, Ministry of Education; School of Chemistry and Materials Science, Anhui Normal University, Wuhu, 241002, China. and Department of Chemical and Chemical Engineering, Hefei Normal University, Hefei, 230601, China
| | - Noël Boens
- Department of Chemistry, KU Leuven (Katholieke Universiteit Leuven), Celestijnenlaan 200f, 3001 Heverlee, Belgium
| | - Lijuan Jiao
- Laboratory of Functional Molecular Solids, Ministry of Education; School of Chemistry and Materials Science, Anhui Normal University, Wuhu, 241002, China.
| | - Erhong Hao
- Laboratory of Functional Molecular Solids, Ministry of Education; School of Chemistry and Materials Science, Anhui Normal University, Wuhu, 241002, China.
| |
Collapse
|
8
|
Borgarelli C, Klingl YE, Escamilla-Ayala A, Munck S, Van Den Bosch L, De Borggraeve WM, Ismalaj E. Lighting Up the Plasma Membrane: Development and Applications of Fluorescent Ligands for Transmembrane Proteins. Chemistry 2021; 27:8605-8641. [PMID: 33733502 DOI: 10.1002/chem.202100296] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/25/2021] [Indexed: 12/16/2022]
Abstract
Despite the fact that transmembrane proteins represent the main therapeutic targets for decades, complete and in-depth knowledge about their biochemical and pharmacological profiling is not fully available. In this regard, target-tailored small-molecule fluorescent ligands are a viable approach to fill in the missing pieces of the puzzle. Such tools, coupled with the ability of high-precision optical techniques to image with an unprecedented resolution at a single-molecule level, helped unraveling many of the conundrums related to plasma proteins' life-cycle and druggability. Herein, we review the recent progress made during the last two decades in fluorescent ligand design and potential applications in fluorescence microscopy of voltage-gated ion channels, ligand-gated ion channels and G-coupled protein receptors.
Collapse
Affiliation(s)
- Carlotta Borgarelli
- Department of Chemistry, Molecular Design and Synthesis, KU Leuven Campus Arenberg Celestijnenlaan 200F -, box 2404, 3001, Leuven, Belgium
| | - Yvonne E Klingl
- Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven Campus Gasthuisberg O&N5 -, box 602 Herestraat 49, 3000, Leuven, Belgium.,Laboratory of Neurobiology, VIB, Center for Brain &, Disease Research, VIB-KU Leuven Campus Gasthuisberg O&N5 -, box 602 Herestraat 49, 3000, Leuven, Belgium
| | - Abril Escamilla-Ayala
- Center for Brain & Disease Research, & VIB BioImaging Core, VIB-KU Leuven Campus Gasthuisberg O&N5 -, box 602 Herestraat 49, 3000, Leuven, Belgium.,Department of Neurosciences, Leuven Brain Institute, KU Leuven, Campus Gasthuisberg O&N5 - box 602 Herestraat 49, 3000, Leuven, Belgium
| | - Sebastian Munck
- Center for Brain & Disease Research, & VIB BioImaging Core, VIB-KU Leuven Campus Gasthuisberg O&N5 -, box 602 Herestraat 49, 3000, Leuven, Belgium.,Department of Neurosciences, Leuven Brain Institute, KU Leuven, Campus Gasthuisberg O&N5 - box 602 Herestraat 49, 3000, Leuven, Belgium
| | - Ludo Van Den Bosch
- Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven Campus Gasthuisberg O&N5 -, box 602 Herestraat 49, 3000, Leuven, Belgium.,Laboratory of Neurobiology, VIB, Center for Brain &, Disease Research, VIB-KU Leuven Campus Gasthuisberg O&N5 -, box 602 Herestraat 49, 3000, Leuven, Belgium
| | - Wim M De Borggraeve
- Department of Chemistry, Molecular Design and Synthesis, KU Leuven Campus Arenberg Celestijnenlaan 200F -, box 2404, 3001, Leuven, Belgium
| | - Ermal Ismalaj
- Department of Chemistry, Molecular Design and Synthesis, KU Leuven Campus Arenberg Celestijnenlaan 200F -, box 2404, 3001, Leuven, Belgium
| |
Collapse
|
9
|
Szepesi Kovács D, Hajdu I, Mészáros G, Wittner L, Meszéna D, Tóth EZ, Hegedűs Z, Ranđelović I, Tóvári J, Szabó T, Szilágyi B, Milen M, Keserű GM, Ábrányi-Balogh P. Synthesis and characterization of new fluorescent boro-β-carboline dyes. RSC Adv 2021; 11:12802-12807. [PMID: 35423835 PMCID: PMC8697281 DOI: 10.1039/d1ra02132j] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2021] [Accepted: 03/24/2021] [Indexed: 12/12/2022] Open
Abstract
The first representatives of the new fluorescent boro-β-carboline family were synthesized by the insertion of the difluoroboranyl group into the oxaza or diaza core. The resulting compounds showed good photophysical properties with fine Stokes-shifts in the range of 38-85 nm with blue and green emission. The energetics of the excitation states and molecular orbitals of two members were investigated by quantum chemical computations suggesting effects for the improved properties of diazaborinino-carbolines over oxazaborolo-carbolines. These properties nominated this chemotype as a new fluorophore for the development of fluorescent probes. As an example, diazaborinino-carbolines were used for the specific labeling of anti-Her2 antibody trastuzumab. The fluorescent conjugate showed a high fluorophore-antibody ratio and was confirmed as a useful tool for labeling and confocal microscopy imaging of tumour cells in vitro together with the ex vivo two-photon microscopy imaging of tumour slices.
Collapse
Affiliation(s)
- Dénes Szepesi Kovács
- Research Centre for Natural Sciences, Medicinal Chemistry Research Group POB 286 1519 Budapest Hungary +36-13826961
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics 1521 Budapest Hungary
| | - Imre Hajdu
- Research Centre for Natural Sciences, Medicinal Chemistry Research Group POB 286 1519 Budapest Hungary +36-13826961
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics 1521 Budapest Hungary
| | - Gergely Mészáros
- Research Centre for Natural Sciences, Comparative Psychophysiology Research Group POB 286 1519 Budapest Hungary
- Faculty of Information Technology and Bionics, Pázmány Péter Catholic University POB 278 1444 Budapest Hungary
| | - Lucia Wittner
- Research Centre for Natural Sciences, Comparative Psychophysiology Research Group POB 286 1519 Budapest Hungary
| | - Domokos Meszéna
- Research Centre for Natural Sciences, Comparative Psychophysiology Research Group POB 286 1519 Budapest Hungary
- Faculty of Information Technology and Bionics, Pázmány Péter Catholic University POB 278 1444 Budapest Hungary
| | - Estilla Zsófia Tóth
- Research Centre for Natural Sciences, Comparative Psychophysiology Research Group POB 286 1519 Budapest Hungary
- János Szentágothai Doctoral School of Neurosciences, Semmelweis University 1085 Budapest Hungary
| | - Zita Hegedűs
- National Institute of Oncology, Department of Experimental Pharmacology POB 21 1525 Budapest Hungary
| | - Ivan Ranđelović
- National Institute of Oncology, Department of Experimental Pharmacology POB 21 1525 Budapest Hungary
| | - József Tóvári
- National Institute of Oncology, Department of Experimental Pharmacology POB 21 1525 Budapest Hungary
| | - Tímea Szabó
- Egis Pharmaceuticals Plc., Directorate of Drug Substance Development POB 100 1475 Budapest Hungary
| | - Bence Szilágyi
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics 1521 Budapest Hungary
| | - Mátyás Milen
- Egis Pharmaceuticals Plc., Directorate of Drug Substance Development POB 100 1475 Budapest Hungary
| | - György Miklós Keserű
- Research Centre for Natural Sciences, Medicinal Chemistry Research Group POB 286 1519 Budapest Hungary +36-13826961
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics 1521 Budapest Hungary
| | - Péter Ábrányi-Balogh
- Research Centre for Natural Sciences, Medicinal Chemistry Research Group POB 286 1519 Budapest Hungary +36-13826961
- Department of Organic Chemistry and Technology, Budapest University of Technology and Economics 1521 Budapest Hungary
| |
Collapse
|
10
|
Boutin JA, Witt-Enderby PA, Sotriffer C, Zlotos DP. Melatonin receptor ligands: A pharmaco-chemical perspective. J Pineal Res 2020; 69:e12672. [PMID: 32531076 DOI: 10.1111/jpi.12672] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/09/2020] [Revised: 05/19/2020] [Accepted: 06/04/2020] [Indexed: 12/14/2022]
Abstract
Melatonin MT1 and MT2 receptor ligands have been vigorously explored for the last 4 decades. Inspection of approximately 80 publications in the field revealed that most melatonergic ligands were structural analogues of melatonin combining three essential features of the parent compound: an aromatic ring bearing a methoxy group and an amide side chain in a relative arrangement similar to that present in melatonin. While several series of MT2 -selective agents-agonists, antagonists, or partial agonists-were reported, the field was lacking MT1 -selective agents. Herein, we describe various approaches toward the development of melatonergic ligands, keeping in mind that most of the molecules/pharmacophores obtained were essentially melatonin copies, even though diverse tri- or tetra-cyclic compounds were explored. In addition to lack of structural diversity, only few studies examined the activity of the reported melatonergic ligands in vivo. Moreover, an extensive pharmacological characterization including biopharmaceutical stability, pharmacokinetic properties, specificity toward other major receptors to name a few remained scarce. For example, many of the antagonists described were not stable in vivo, were not selective for the melatonin receptor subtype of interest, and were not fully characterized from a pharmacological standpoint. Indeed, virtual screening of large compound libraries has led to the recent discovery of potent and selective melatonin receptor agonists and partial agonists of new chemotypes. Having said this, the melatonergic field is still lacking subtype-selective melatonin receptor antagonists "active" in vivo, which are critical to our understanding of melatonin and melatonin receptors' role in basic physiology and disease.
Collapse
MESH Headings
- Animals
- Humans
- Ligands
- Melatonin/chemistry
- Receptor, Melatonin, MT1/agonists
- Receptor, Melatonin, MT1/antagonists & inhibitors
- Receptor, Melatonin, MT1/chemistry
- Receptor, Melatonin, MT2/agonists
- Receptor, Melatonin, MT2/antagonists & inhibitors
- Receptor, Melatonin, MT2/chemistry
Collapse
Affiliation(s)
- Jean A Boutin
- Institut de Recherches Internationales SERVIER, Suresnes, France
| | - Paula A Witt-Enderby
- School of Pharmacy & Graduate School of Pharmaceutical, Administrative and Social Sciences, Duquesne University, Pittsburg, PA, USA
| | - Christoph Sotriffer
- Institute of Pharmacy and Food Chemistry, University of Würzburg, Würzburg, Germany
| | - Darius P Zlotos
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, The German University in Cairo, New Cairo City, Egypt
| |
Collapse
|
11
|
Wang SY, Shi XC, Laborda P. Indole-based melatonin analogues: Synthetic approaches and biological activity. Eur J Med Chem 2020; 185:111847. [DOI: 10.1016/j.ejmech.2019.111847] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2019] [Revised: 11/01/2019] [Accepted: 11/01/2019] [Indexed: 12/11/2022]
|
12
|
|
13
|
Abstract
The development of persulfate-mediated oxidation of tetrahydro-β-carbolines is reported. This mild reaction facilitates the formation of a variety of 2-formyl N-substituted tryptamines and the related derivatives as key intermediates in moderate to excellent yields. The method is applicable to direct last-stage oxidation of two interesting pharmaceuticals, Cialis and evodiamine.
Collapse
Affiliation(s)
- Haijun Chen
- Key Laboratory of Molecule Synthesis and Function Discovery (Fujian Province University), College of Chemistry , Fuzhou University , Fuzhou , Fujian 350116 , China
| | - Fu Ye
- Key Laboratory of Molecule Synthesis and Function Discovery (Fujian Province University), College of Chemistry , Fuzhou University , Fuzhou , Fujian 350116 , China
| | - Jing Luo
- Key Laboratory of Molecule Synthesis and Function Discovery (Fujian Province University), College of Chemistry , Fuzhou University , Fuzhou , Fujian 350116 , China
| | - Yu Gao
- Key Laboratory of Molecule Synthesis and Function Discovery (Fujian Province University), College of Chemistry , Fuzhou University , Fuzhou , Fujian 350116 , China
| |
Collapse
|
14
|
Didukh NO, Yakubovskyi VP, Zatsikha YV, Rohde GT, Nemykin VN, Kovtun YP. Flexible BODIPY Platform That Offers an Unexpected Regioselective Heterocyclization Reaction toward Preparation of 2-Pyridone[a]-Fused BODIPYs. J Org Chem 2019; 84:2133-2147. [DOI: 10.1021/acs.joc.8b03119] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Natalia O. Didukh
- Institute of Organic Chemistry, National Academy of Sciences of Ukraine, 5 Murmanska str., 02660 Kyiv, Ukraine
- Department of Chemistry, University of Manitoba, Winnipeg, MB R3T 2N2, Canada
| | - Viktor P. Yakubovskyi
- Institute of Organic Chemistry, National Academy of Sciences of Ukraine, 5 Murmanska str., 02660 Kyiv, Ukraine
| | - Yuriy V. Zatsikha
- Department of Chemistry, University of Manitoba, Winnipeg, MB R3T 2N2, Canada
| | | | - Victor N. Nemykin
- Department of Chemistry, University of Manitoba, Winnipeg, MB R3T 2N2, Canada
| | - Yuriy P. Kovtun
- Institute of Organic Chemistry, National Academy of Sciences of Ukraine, 5 Murmanska str., 02660 Kyiv, Ukraine
| |
Collapse
|
15
|
Iliopoulos-Tsoutsouvas C, Kulkarni RN, Makriyannis A, Nikas SP. Fluorescent probes for G-protein-coupled receptor drug discovery. Expert Opin Drug Discov 2018; 13:933-947. [DOI: 10.1080/17460441.2018.1518975] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Affiliation(s)
| | - Rohit N. Kulkarni
- Section on Islet Cell and Regenerative Biology, Joslin Diabetes Center. Department of Medicine, Brigham and Women’s Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts, USA
| | - Alexandros Makriyannis
- Center for Drug Discovery and Departments of Chemistry & Chemical Biology and Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, USA
| | - Spyros P. Nikas
- Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, USA
| |
Collapse
|
16
|
Cecon E, Oishi A, Jockers R. Melatonin receptors: molecular pharmacology and signalling in the context of system bias. Br J Pharmacol 2018; 175:3263-3280. [PMID: 28707298 PMCID: PMC6057902 DOI: 10.1111/bph.13950] [Citation(s) in RCA: 154] [Impact Index Per Article: 25.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2017] [Revised: 07/05/2017] [Accepted: 07/10/2017] [Indexed: 12/15/2022] Open
Abstract
Melatonin, N-acetyl-5-methoxytryptamine, an evolutionally old molecule, is produced by the pineal gland in vertebrates, and it binds with high affinity to melatonin receptors, which are members of the GPCR family. Among the multiple effects attributed to melatonin, we will focus here on those that are dependent on the activation of the two mammalian MT1 and MT2 melatonin receptors. We briefly summarize the latest developments on synthetic melatonin receptor ligands, including multi-target-directed ligands, and the characterization of signalling-biased ligands. We discuss signalling pathways activated by melatonin receptors that appear to be highly cell- and tissue-dependent, emphasizing the impact of system bias on the functional outcome. Different proteins have been demonstrated to interact with melatonin receptors, and thus, we postulate that part of this system bias has its molecular basis in differences of the expression of receptor-associated proteins including heterodimerization partners. Finally, bias at the level of the receptor, by the expression of genetic receptor variants, will be discussed to show how a modified receptor function can have an effect on the risk for common diseases like type 2 diabetes in humans. LINKED ARTICLES: This article is part of a themed section on Recent Developments in Research of Melatonin and its Potential Therapeutic Applications. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.16/issuetoc.
Collapse
Affiliation(s)
- Erika Cecon
- Institut CochinInserm, U1016ParisFrance
- CNRS UMR 8104ParisFrance
- Univ. Paris Descartes, Sorbonne Paris CitéParisFrance
| | - Atsuro Oishi
- Institut CochinInserm, U1016ParisFrance
- CNRS UMR 8104ParisFrance
- Univ. Paris Descartes, Sorbonne Paris CitéParisFrance
| | - Ralf Jockers
- Institut CochinInserm, U1016ParisFrance
- CNRS UMR 8104ParisFrance
- Univ. Paris Descartes, Sorbonne Paris CitéParisFrance
| |
Collapse
|
17
|
Oishi A, Cecon E, Jockers R. Melatonin Receptor Signaling: Impact of Receptor Oligomerization on Receptor Function. INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY 2018; 338:59-77. [DOI: 10.1016/bs.ircmb.2018.02.002] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
|
18
|
Gbahou F, Cecon E, Viault G, Gerbier R, Jean-Alphonse F, Karamitri A, Guillaumet G, Delagrange P, Friedlander RM, Vilardaga JP, Suzenet F, Jockers R. Design and validation of the first cell-impermeant melatonin receptor agonist. Br J Pharmacol 2017; 174:2409-2421. [PMID: 28493341 DOI: 10.1111/bph.13856] [Citation(s) in RCA: 46] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2017] [Revised: 04/27/2017] [Accepted: 05/03/2017] [Indexed: 12/14/2022] Open
Abstract
BACKGROUND AND PURPOSE The paradigm that GPCRs are able to prolong or initiate cellular signalling through intracellular receptors recently emerged. Melatonin binds to G protein-coupled MT1 and MT2 receptors. In contrast to most other hormones targeting GPCRs, melatonin and its synthetic analogues are amphiphilic molecules easily penetrating into cells, but the existence of intracellular receptors is still unclear mainly due to a lack of appropriate tools. EXPERIMENTAL APPROACH We therefore designed and synthesized a series of hydrophilic melatonin receptor ligands coupled to the Cy3 cyanin fluorophore to reliably monitor its inability to penetrate cells. Two compounds, one lipophilic and one hydrophilic, were then functionally characterized in terms of their affinity for human and murine melatonin receptors expressed in HEK293 cells and their signalling efficacy. KEY RESULTS Among the different ligands, ICOA-13 showed the desired properties as it was cell-impermeant and bound to human and mouse MT1 and MT2 receptors. ICOA-13 showed differential activities on melatonin receptors ranging from partial to full agonistic properties for the Gi /cAMP and ERK pathway and β-arrestin 2 recruitment. Notably, ICOA-13 enabled us to discriminate between Gi /cAMP signalling of the MT1 receptor initiated at the cell surface and neuronal mitochondria. CONCLUSIONS AND IMPLICATIONS We report here the first cell-impermeant melatonin receptor agonist, ICOA-13, which allows us to discriminate between signalling events initiated at the cell surface and intracellular compartments. Detection of mitochondrial MT1 receptors may have an important impact on the development of novel melatonin receptor ligands relevant for neurodegenerative diseases, such as Huntington disease.
Collapse
Affiliation(s)
- Florence Gbahou
- Inserm, U1016, Institut Cochin, Paris, France.,CNRS UMR 8104, Paris, France.,Université Paris Descartes, Paris, France
| | - Erika Cecon
- Inserm, U1016, Institut Cochin, Paris, France.,CNRS UMR 8104, Paris, France.,Université Paris Descartes, Paris, France
| | - Guillaume Viault
- Institut de Chimie Organique et Analytique (ICOA), Université d'Orléans, UMR CNRS 7311, B.P. 6759, Orléans Cedex 2, France
| | - Romain Gerbier
- Inserm, U1016, Institut Cochin, Paris, France.,CNRS UMR 8104, Paris, France.,Université Paris Descartes, Paris, France
| | - Frederic Jean-Alphonse
- Laboratory for GPCR Biology, Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
| | - Angeliki Karamitri
- Inserm, U1016, Institut Cochin, Paris, France.,CNRS UMR 8104, Paris, France.,Université Paris Descartes, Paris, France
| | - Gérald Guillaumet
- Institut de Chimie Organique et Analytique (ICOA), Université d'Orléans, UMR CNRS 7311, B.P. 6759, Orléans Cedex 2, France
| | - Philippe Delagrange
- Pôle d'Innovation Thérapeutique Neuropsychiatrie, Institut de Recherches Servier, Croissy, France
| | - Robert M Friedlander
- Neuroapoptosis Laboratory, Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA
| | - Jean-Pierre Vilardaga
- Laboratory for GPCR Biology, Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
| | - Franck Suzenet
- Institut de Chimie Organique et Analytique (ICOA), Université d'Orléans, UMR CNRS 7311, B.P. 6759, Orléans Cedex 2, France
| | - Ralf Jockers
- Inserm, U1016, Institut Cochin, Paris, France.,CNRS UMR 8104, Paris, France.,Université Paris Descartes, Paris, France
| |
Collapse
|
19
|
Viault G, Poupart S, Mourlevat S, Lagaraine C, Devavry S, Lefoulon F, Bozon V, Dufourny L, Delagrange P, Guillaumet G, Suzenet F. Design, synthesis and biological evaluation of fluorescent ligands for MT1 and/or MT2 melatonin receptors. RSC Adv 2016. [DOI: 10.1039/c6ra10812a] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Fluorescent melatoninergic ligands have been designed by associating the 4-azamelatonin ligands with different fluorophores.
Collapse
Affiliation(s)
- G. Viault
- Institut de Chimie Organique et Analytique
- Université d’Orléans
- UMR CNRS 7311
- 45067 Orléans Cedex 2
- France
| | - S. Poupart
- Institut de Chimie Organique et Analytique
- Université d’Orléans
- UMR CNRS 7311
- 45067 Orléans Cedex 2
- France
| | | | | | | | | | - V. Bozon
- PRC
- INRA
- CNRS
- IFCE
- Université de Tours
| | | | - P. Delagrange
- Institut de Recherche Servier
- Sciences Expérimentales
- 78290 Croissy
- France
| | - G. Guillaumet
- Institut de Chimie Organique et Analytique
- Université d’Orléans
- UMR CNRS 7311
- 45067 Orléans Cedex 2
- France
| | - F. Suzenet
- Institut de Chimie Organique et Analytique
- Université d’Orléans
- UMR CNRS 7311
- 45067 Orléans Cedex 2
- France
| |
Collapse
|
20
|
New coumarin-based fluorescent melatonin ligands. Design, synthesis and pharmacological characterization. Eur J Med Chem 2015; 103:370-3. [DOI: 10.1016/j.ejmech.2015.09.003] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2015] [Revised: 09/01/2015] [Accepted: 09/02/2015] [Indexed: 11/17/2022]
|
21
|
Boens N, Verbelen B, Dehaen W. Postfunctionalization of the BODIPY Core: Synthesis and Spectroscopy. European J Org Chem 2015. [DOI: 10.1002/ejoc.201500682] [Citation(s) in RCA: 234] [Impact Index Per Article: 26.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
|
22
|
Lv J, Zha X, Pang S, Jia H, Zhang Y, Shang J. Synthesis and melanogenesis evaluation of 3′,4′,7-trihydroxyflavanone derivatives and characterization of flavanone–BODIPY. Bioorg Med Chem Lett 2015; 25:1607-10. [DOI: 10.1016/j.bmcl.2015.01.072] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2014] [Revised: 01/20/2015] [Accepted: 01/30/2015] [Indexed: 11/28/2022]
|